Chris Serpell
@cjserpell.bsky.social
790 followers
390 following
69 posts
Assoc. Prof. of Drug Discovery at UCL School of Pharmacy. Weird-y nucleic acids, chem. bio. of natural products. Catholic. https://blogs.ucl.ac.uk/serpell/
Posts
Media
Videos
Starter Packs
Chris Serpell
@cjserpell.bsky.social
· Aug 26
Reposted by Chris Serpell
Chris Serpell
@cjserpell.bsky.social
· Jul 16
Sequence-defined phosphoestamers for selective inhibition of the KRASG12D/RAF1 interaction
RAS proteins are the most frequently mutated in cancer, yet they have proved extremely difficult to target in drug discovery, largely because interfering with the interaction of RAS with its downstrea...
pubs.rsc.org
Chris Serpell
@cjserpell.bsky.social
· Jul 10
Chris Serpell
@cjserpell.bsky.social
· Jul 10
Chris Serpell
@cjserpell.bsky.social
· Jul 3
Chris Serpell
@cjserpell.bsky.social
· Jul 3
Chris Serpell
@cjserpell.bsky.social
· Jul 1
Chris Serpell
@cjserpell.bsky.social
· Jun 30
Chris Serpell
@cjserpell.bsky.social
· Jun 27
Chris Serpell
@cjserpell.bsky.social
· Jun 24
Chris Serpell
@cjserpell.bsky.social
· Jun 20
Chris Serpell
@cjserpell.bsky.social
· Jun 18
Chris Serpell
@cjserpell.bsky.social
· Jun 18
Reposted by Chris Serpell
Reposted by Chris Serpell
Andrew Beekman
@andrewbeekman.bsky.social
· Feb 14
Peptide design to control protein–protein interactions
Targeting of protein–protein interactions has become of huge interest in every aspect of medicinal and biological sciences. The control of protein interactions selectively offers the opportunity to co...
doi.org
Chris Serpell
@cjserpell.bsky.social
· Feb 14
Reposted by Chris Serpell